drugset
drugset / Trial / NCT01913847

Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension

NCT01913847 ↗

Phase 3 Unknown 144 enrolled Hanmi Pharmaceutical Company Limited
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate the safety and clinical efficacy of HGP1207 (Sildenafil) in subjects with pulmonary hypertension associated with systolic heart failure.

Timeline

Start
2013-09
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 20 mg Oral

Indications

pulmonary hypertension systolic heart failure